2 top shares I’ve bought for my Stocks and Shares ISA in November

This writer reveals a pair of fast-growing businesses that he’s recently added to his Stocks and Shares ISA for the long term.

| More on:

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

So far this month, I’ve added two companies to my Stocks and Shares ISA. One is an established FTSE 100 giant, while the other is a newer but surprisingly large Brazilian enterprise.

Bought at $14

First up is Nu Holdings (NYSE: NU), commonly known as Nubank. Despite being largely unknown in the West, this is Latin America’s biggest digital bank with a $75bn market cap.

In fact, it’s the largest online-only bank outside of China and is backed by Warren Buffett!

The share price is up around 90% year to date. And while some investors might baulk at a stock that’s already doing well, there’s a lot to like here, in my opinion.

For starters, the digital lender had 104.5m customers at the end of June. That’s up from 33.3m at the end of 2021 — an astonishing 214% increase. And it currently only operates in three countries — Brazil, Colombia, and Mexico — in a region with approximately 465m adults.

This eye-popping growth highlights how scalable the firm’s low-cost app is compared to bricks-and-mortar competitors. In Q2, revenue jumped 65% year on year to $2.8bn (on a constant-currency basis). Adjusted net income surged 138% to $563m.

Nubank continues to expand its ecosystem beyond savings, loans and insurance. Its Nu Shopping feature, which offers customers discounted access to hundreds of retail partners, is growing rapidly. And it’s just launched a mobile phone service (NuCel) in Brazil.

One risk here is increasing competition, especially from e-commerce and fintech giant MercadoLibre. Also, any sudden slowdown in growth or rise in non-performing loans, could spark a sell-off in the shares.

Looking ahead though, the company appears perfectly positioned to continue growing. According to Latin America Reports, seven in 10 people in the region are unbanked or underbanked. But over 80% now have mobile phones, so this is fertile ground for digital banking and e-commerce growth.

The stock is trading at 26 times forward earnings and five times next year’s sales. A premium yes, but attractive to me given the growth potential.

Bought at £98

The second firm is AstraZeneca (LSE: AZN), in which I recently bought more shares. This followed a 19% drop in the FTSE 100 stock in the space of three weeks.

The reason is China, where its president was detained by authorities last week. This appears related to a large insurance fraud investigation, but we don’t still know exact details.

China is the firm’s second-largest market, contributing 13% of revenue last year. Understandably, the pharma giant is taking these matters “very seriously“. There’s suddenly a lot of uncertainty here.

Looking past this, however, the business is thriving. Today (12 November), it reported that total revenue and core earnings per share (EPS) were up 21% and 27%, respectively, in the third quarter. Both figures beat analysts’ expectations.

CEO Pascal Soriot commented: “Growth looks set to continue through 2025, providing a solid foundation to deliver on our 2030 ambition.” That’s for $80bn in revenue by 2030, up from $45.8bn in 2023.

After this strong performance, Astra now sees high-teens percentage growth in full-year revenue and core EPS, up from a previous forecast of mid-teens growth at constant currency rates.

The stock is 20% cheaper than it was just one month ago. In my eyes, this appears to be a classic buy-the-dip opportunity for me. But only time will tell.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Ben McPoland has positions in AstraZeneca Plc, MercadoLibre, and Nu Holdings. The Motley Fool UK has recommended AstraZeneca Plc, MercadoLibre, and Nu Holdings. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Should I sell my FTSE All-Share index fund and buy a S&P 500 tracker instead?

Harvey Jones is wondering whether now is a good time to invest more money in the S&P 500, after a…

Read more »

Investing Articles

Should I buy dirt-cheap BT shares after the recent pullback?

BT shares were on the up but now they're sliding again after the board trimmed full-year guidance. Now Harvey Jones…

Read more »

Investing Articles

Up 28%, can the easyJet share price keep rising?

The easyJet share price has gained altitude over one year but plunged over five. Is now an attractive time for…

Read more »

British Isles on nautical map
Investing Articles

Should I buy more BAE Systems shares at 1,350p?

BAE Systems shares have had a fantastic run since early 2022, yet still don't appear overvalued. Is it now time…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

7% yield and a cheap valuation! Is this one of the best shares to buy this month?

Christopher Ruane has been looking for cheap shares to buy. This one has a 7% dividend yield, so is it…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

Should I buy National Grid shares for the big dividend before it’s too late?

This year's price weakness has left National Grid shares on what looks like a tempting valuation. I hope it doesn't…

Read more »

Investing Articles

There are now 5,000 ISA millionaires! See the surprising UK dividend shares they’re buying

The number of ISA millionaires is growing all the time and guess what? They're really into blue-chip dividend shares listed…

Read more »

Blue NIO sports car in Oslo showroom
Investing Articles

Down 38% in weeks! Time to snap up NIO stock?

NIO stock's more than doubled in value over the past five years but has been on a wild ride lately.…

Read more »